Description of 3,180 Courses of Chelation with Dimercaptosuccinic Acid in Children ≤5 y with Severe Lead Poisoning in Zamfara, Northern Nigeria: A Retrospective Analysis of Programme Data
暂无分享,去创建一个
M. Kosnett | P. Dargan | Y. Amitai | C. Ariti | Mary Jean Brown | H. Akpan | L. Cooney | L. Shanks | J. Greig | Natalie Thurtle | K. Moussally | N. Sani-Gwarzo | M. Brown
[1] K. Caldwell,et al. Analysis of a novel field dilution method for testing samples that exceed the analytic range of point-of-care blood lead analyzers , 2014, International journal of environmental health research.
[2] P. Dargan,et al. Association of Blood Lead Level with Neurological Features in 972 Children Affected by an Acute Severe Lead Poisoning Outbreak in Zamfara State, Northern Nigeria , 2014, PloS one.
[3] Ord,et al. Guidance on Selecting Age Groups for Monitoring and Assessing Childhood Exposures to Environmental Contaminants , 2013 .
[4] Sophia Rabe-Hesketh,et al. Multilevel and Longitudinal Modeling Using Stata, Volumes I and II, Third Edition: Multilevel and Longitudinal Modeling Using Stata, Volume II ... Counts, and Survival, Third Edition , 2012 .
[5] Nasir Sani-Gwarzo,et al. Outbreak of Fatal Childhood Lead Poisoning Related to Artisanal Gold Mining in Northwestern Nigeria, 2010 , 2011, Environmental health perspectives.
[6] M. Kosnett. Chelation for Heavy Metals (Arsenic, Lead, and Mercury): Protective or Perilous? , 2010, Clinical pharmacology and therapeutics.
[7] Y. Amitai,et al. Lead poisoning among internally displaced Roma, Ashkali and Egyptian children in the United Nations-Administered Province of Kosovo. , 2010, European journal of public health.
[8] A. Vale,et al. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning , 2009, Clinical toxicology.
[9] A. Vale,et al. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning. , 2009, QJM : monthly journal of the Association of Physicians.
[10] A. Vale,et al. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning , 2009, Clinical toxicology.
[11] Shunqin Wang,et al. Blood lead levels of children and its trend in China. , 2009, The Science of the total environment.
[12] R. Bertollini,et al. Mass Lead Intoxication from Informal Used Lead-Acid Battery Recycling in Dakar, Senegal , 2009, Environmental health perspectives.
[13] Sophia Rabe-Hesketh,et al. Multilevel and longitudinal modeling using Stata. 2nd edition , 2008 .
[14] S. Kales,et al. Lead encephalopathy due to traditional medicines. , 2008, Current drug safety.
[15] M. Brown,et al. Evaluation and recommendations for preventing lead poisoning among the internally displaced Roma population in Kosovo from the Centers for Disease Control and Prevention , 2007 .
[16] N. Horton. Multilevel and Longitudinal Modeling Using Stata , 2006 .
[17] African Lungfish,et al. Standard operating procedures , 2006, Nature Biotechnology.
[18] Death of a child after ingestion of a metallic charm--Minnesota, 2006. , 2006, MMWR. Morbidity and mortality weekly report.
[19] Monica Cheesbrough,et al. District Laboratory Practice in Tropical Countries: Acknowledgements , 2005 .
[20] J. Gibson,et al. A Plea for Painted Railings and Painted Walls of Rooms as the Source of Lead Poisoning Amongst Queensland Children , 2005, Public health reports.
[21] J. Brent. Critical care toxicology : diagnosis and management of the critically poisoned patient , 2005 .
[22] Catherine Anne Kelly,et al. Comparison of consciousness level assessment in the poisoned patient using the alert/verbal/painful/unresponsive scale and the Glasgow Coma Scale. , 2004, Annals of emergency medicine.
[23] J. Coresh,et al. Blood lead and chronic kidney disease in the general United States population: results from NHANES III. , 2003, Kidney international.
[24] Catherine J Staes,et al. Deaths related to lead poisoning in the United States, 1979-1998. , 2003, Environmental research.
[25] J. R. Reigart,et al. The Effect of Chelation Therapy With Succimer on Neuropsychological Development in Children Exposed to Lead , 2003 .
[26] B. Harvey. Managing elevated blood lead levels among young children : recommendations from the Advisory Committee on Childhood Lead Poisoning Prevention , 2002 .
[27] S. Rothenberg,et al. The lead content of blood serum. , 2001, Environmental research.
[28] Robert L. Jones,et al. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. , 2001, The New England journal of medicine.
[29] A. Onalaja,et al. Genetic susceptibility to lead poisoning. , 2000, Environmental health perspectives.
[30] J. Chisolm,et al. Safety and Efficacy of Meso-2,3-Dimercaptosuccinic Acid (DMSA) in Children with Elevated Blood Lead Concentrations , 2000, Journal of toxicology. Clinical toxicology.
[31] Safety and efficacy of succimer in toddlers with blood lead levels of 20-44 microg/dL. Treatment of Lead-Exposed Children (TLC) Trial Group. , 2000, Pediatric research.
[32] George G. Rhoads,et al. Safety and Efficacy of Succimer in Toddlers with Blood Lead Levels of 20–44 μg/dL , 2000, Pediatric Research.
[33] W. Rogan,et al. Treatment of Lead-Exposed Children (TLC) Trial: Effect of Succimer in Toddlers with Blood Leads of 20-44 µg/dl , 1999 .
[34] K. White,et al. A Comparison of Two Dosing Regimens of Succimer in Children with Chronic Lead Poisoning , 1999, Journal of clinical pharmacology.
[35] The Treatment of Lead-exposed Children (TLC) trial: design and recruitment for a study of the effect of oral chelation on growth and development in toddlers. , 1998, Paediatric and perinatal epidemiology.
[36] I. Bergdahl,et al. Lead concentrations in human plasma, urine and whole blood. , 1997, Scandinavian journal of work, environment & health.
[37] E. Prado. [The importance of eosinophils in children with bronchial asthma]. , 1997, Jornal de pediatria.
[38] Michigan.,et al. Toxicological profile for dichloropropenes , 2008 .
[39] P. Bijur,et al. Relationships among blood lead levels, iron deficiency, and cognitive development in two-year-old children. , 1996, Environmental health perspectives.
[40] J. Graziano,et al. Metabolism of meso-2,3-dimercaptosuccinic acid in lead-poisoned children and normal adults. , 1995, Environmental health perspectives.
[41] D. Notterman,et al. Treatment Guidelines for Lead Exposure in Children , 1995, Pediatrics.
[42] K. Hurlbut,et al. Pharmacokinetics of meso-2,3-dimercaptosuccinic acid in patients with lead poisoning and in healthy adults. , 1994, The Journal of pediatrics.
[43] M. Shannon,et al. Efficacy of oral meso-2,3-dimercaptosuccinic acid therapy for low-level childhood plumbism. , 1994, The Journal of pediatrics.
[44] B. Dean,et al. Ceramic lead glaze ingestions in nursing home residents with dementia. , 1994, The American journal of emergency medicine.
[45] V. Slavkovich,et al. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication. , 1992, The Journal of pediatrics.
[46] J. Chisolm,et al. Evaluation of the potential role of chelation therapy in treatment of low to moderate lead exposures. , 1990, Environmental health perspectives.
[47] J. Graziano,et al. Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations. , 1988, The Journal of pediatrics.
[48] J. Graziano,et al. Dose-response study of oral 2,3-dimercaptosuccinic acid with elevated blood lead concentrations in children , 1988 .
[49] D. Moel,et al. Slow, natural reduction in blood lead level after chelation therapy for lead poisoning in childhood. , 1986, American journal of diseases of children.
[50] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[51] J. Graziano,et al. 2,3‐Dimercaptosuccinic acid as an antidote for lead intoxication , 1985, Clinical pharmacology and therapeutics.
[52] D. E. Carter,et al. DMSA, DMPS, and DMPA--as arsenic antidotes. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[53] J. Chisolm. The use of chelating agents in the treatment of acute and chronic lead intoxication in childhood. , 1968, The Journal of pediatrics.
[54] W. Staples,et al. Treatment of lead encephalopathy in children. , 1966, The Journal of pediatrics.
[55] Wang Sc,et al. Chelating therapy with Na-DMS in occupational lead and mercury intoxications. , 1965 .
[56] J. Greengard,et al. ACUTE LEAD ENCEPHALOPATHY IN YOUNG CHILDREN. , 1965, The Journal of pediatrics.
[57] S. C. Wang,et al. Chelating therapy with Na-DMS in occupational lead and mercury intoxications. , 1965, Chinese medical journal.
[58] J. Chisolm,et al. The treatment of acute lead encephalopathy in children. , 1957, Pediatrics.
[59] A. Merklen,et al. [Lead poisoning]. , 1956, Revue medicale de Nancy.
[60] F. Rieders,et al. The efficacy of edathamil calcium disodium in the treatment of occupational lead poisoning. , 1955, Industrial medicine & surgery.
[61] H. Harrison,et al. Treatment of lead encephalopathy with PAL (2.3-dimercaptopropanol). , 1950, Pediatrics.
[62] E. Kaplan,et al. Incidence of Lead Poisoning in the City of Baltimore. , 1942 .